Deciphering the shared mechanisms of Gegen Qinlian Decoction in treating type 2 diabetes and ulcerative colitis via bioinformatics and machine learning
Frontiers in Medicine · 19.06.2024 · 11
DOI: 10.3389/fmed.2024.1406149 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Medicine, online erschienen am 19.06.2024. Verfasst von Faquan Hu und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Traditional Chinese Medicine, Anhui University of Chinese Medicine, Hefei, China. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Künstliche Intelligenz in der Pflege, Diabetes mellitus
Abstract (Originalsprache)
Background
Although previous clinical studies and animal experiments have demonstrated the efficacy of Gegen Qinlian Decoction (GQD) in treating Type 2 Diabetes Mellitus (T2DM) and Ulcerative Colitis (UC), the underlying mechanisms of its therapeutic effects remain elusive.
Purpose
This study aims to investigate the shared pathogenic mechanisms between T2DM and UC and elucidate the mechanisms through which GQD modulates these diseases using bioinformatics approaches.
Methods
Data for this study were sourced from the Gene Expression Omnibus (GEO) database. Targets of GQD were identified using PharmMapper and SwissTargetPrediction, while targets associated with T2DM and UC were compiled from the DrugBank, GeneCards, Therapeutic Target Database (TTD), DisGeNET databases, and differentially expressed genes (DEGs). Our analysis encompassed six approaches: weighted gene co-expression network analysis (WGCNA), immune infiltration analysis, single-cell sequencing analysis, machine learning, DEG analysis, and network pharmacology.
Results
Through GO and KEGG analysis of weighted gene co-expression network analysis (WGCNA) modular genes and DEGs intersection, we found that the co-morbidity between T2DM and UC is primarily associated with immune-inflammatory pathways, including IL-17, TNF, chemokine, and toll-like receptor signaling pathways. Immune infiltration analysis supported these findings. Three distinct machine learning studies identified IGFBP3 as a biomarker for GQD in treating T2DM, while BACE2, EPHB4, and EPHA2 emerged as biomarkers for GQD in UC treatment. Network pharmacology revealed that GQD treatment for T2DM and UC mainly targets immune-inflammatory pathways like Toll-like receptor, IL-17, TNF, MAPK, and PI3K-Akt signaling pathways.
Conclusion
This study provides insights into the shared pathogenesis of T2DM and UC and clarifies the regulatory mechanisms of GQD on these conditions. It also proposes novel targets and therapeutic strategies for individuals suffering from T2DM and UC.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Traditional Chinese Medicine, Anhui University of Chinese Medicine, Hefei, China.
Zitieren
APA
Hu, F., Xiong, L., Li, Z., Li, L., Wang, L., Wang, X., Zhou, X., & Zheng, Y. (2024). Deciphering the shared mechanisms of Gegen Qinlian Decoction in treating type 2 diabetes and ulcerative colitis via bioinformatics and machine learning. Frontiers in Medicine, 11. https://doi.org/10.3389/fmed.2024.1406149
Vancouver
Hu F, Xiong L, Li Z, Li L, Wang L, Wang X, et al. Deciphering the shared mechanisms of Gegen Qinlian Decoction in treating type 2 diabetes and ulcerative colitis via bioinformatics and machine learning. Frontiers in Medicine. 2024;11. doi:10.3389/fmed.2024.1406149
BibTeX
@article{Hu2024,
author = {Hu, Faquan and Xiong, Liyuan and Li, Zhengpin and Li, Lingxiu and Wang, Li and Wang, Xinheng and Zhou, Xuemei and Zheng, Yujiao},
title = {Deciphering the shared mechanisms of Gegen Qinlian Decoction in treating type 2 diabetes and ulcerative colitis via bioinformatics and machine learning},
journal = {Frontiers in Medicine},
year = {2024},
volume = {11},
doi = {10.3389/fmed.2024.1406149}
}
EUVIMED